Deals
China Online Pharmacy Ecmoho Plans $100 Million U.S. IPO
- Company is working with advisers on the potential offering
- Ecmoho also manufactures supplements and operates care center
This article is for subscribers only.
Ecmoho, an online marketplace for drugs and supplements, is planning a U.S. initial public offering, according to people with knowledge of the matter.
The Shanghai-based company is working with advisers on the planned offering that could raise about $100 million, the people said. The share sale could happen as soon as this year, one of the people said, asking not to be identified because the information is private.